Long-term Results of Endonasal Endoscopic Transsphenoidal Resection of Nonfunctioning Pituitary Macroadenomas

被引:119
|
作者
Dallapiazza, Robert F. [1 ]
Grober, Yuval [1 ]
Starke, Robert M. [1 ]
Laws, Edward R., Jr. [2 ]
Jane, John A., Jr. [1 ]
Fahlbusch, Rudolf
Weiss, Martin H.
Schwartz, Theodore H.
机构
[1] Univ Virginia Hlth Syst, Dept Neurosurg, Charlottesville, VA USA
[2] Brigham & Womens Hosp, Pituitary Neuroendocrine Ctr, Boston, MA 02115 USA
关键词
Endoscopic; Follow-up; Nonfunctioning pituitary macroadenoma; Pituitary tumor; Transsphenoidal; TRANS-SPHENOIDAL SURGERY; CONCURRENT SERIES; ADENOMAS; MANAGEMENT; CLASSIFICATION; MICROSURGERY; RADIOSURGERY; RADIOTHERAPY; RECURRENCE; EXPERIENCE;
D O I
10.1227/NEU.0000000000000563
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
BACKGROUND: Several studies report early results of endoscopic endonasal transsphenoidal surgery; however, none discuss long-term outcome measures such as tumor recurrence rates and the need for additional surgical procedures. OBJECTIVE: To discuss the long-term outcomes after endoscopic endonasal transsphenoidal surgery for nonfunctioning pituitary macroadenomas. METHODS: This is a retrospective study. Patients were included only if they had at least 5 years of clinical and imaging follow-up after surgery. RESULTS: Eighty patients met the study criteria. Grossly complete resection was achieved in 71% of patients. Knosp grade 0 to 2 tumors and tumor with volumes < 10 cm(3) were significantly more likely to have received a grossly complete resection. There were 7 recurrences (12%) in patients who had received grossly complete resections, with a mean time to recurrence of 53 months. Among the 23 patients who had subtotal resections, 11 (61%) progressed radiographically, and 3 (17%) had symptomatic progression. Knosp score, surgical and radiographic evidence of invasion, and preoperative visual deficits were predictive of recurrence in a univariate analysis, but Knosp grade was the only independent predictor in a multivariate analysis. Kaplan-Meier analysis projected a 10-year progression-free survival rate of 80% and 21% for patients with gross total resections and subtotal resections, respectively. CONCLUSION: At the long-term follow-up, 12% of patients had recurrent tumors after grossly complete resection. Recurrent or residual tumors were treated with either repeat surgery or Gamma Knife radiosurgery. Rates of complete resection, postoperative surgical and endocrinological complications, and additional surgical procedures are similar to previously published reports after microscopic transsphenoidal surgery.
引用
收藏
页码:42 / 53
页数:12
相关论文
共 50 条
  • [1] Long-term outcomes after endoscopic endonasal surgery for nonfunctioning pituitary macroadenomas
    Gerges, Mina M.
    Rumalla, Kavelin
    Godil, Saniya S.
    Younus, Iyan
    Elshamy, Walid
    Dobri, Georgiana A.
    Kacker, Ashutosh
    Tabaee, Abtin
    Anand, Viay K.
    Schwartz, Theodore H.
    JOURNAL OF NEUROSURGERY, 2021, 134 (02) : 535 - 546
  • [2] Complications Related to the Endoscopic Endonasal Transsphenoidal Approach for Nonfunctioning Pituitary Macroadenomas in 300 Consecutive Patients
    Magro, Elsa
    Graillon, Thomas
    Lassave, Jerome
    Castinetti, Frederic
    Boissonneau, Sebastien
    Tabouret, Emline
    Fuentes, Stphane
    Velly, Lionel
    Gras, Regis
    Dufour, Henry
    WORLD NEUROSURGERY, 2016, 89 : 442 - 453
  • [3] Visual Outcome of an Endoscopic Endonasal Transsphenoidal Approach in Pituitary Macroadenomas: Quantitative Assessment with Diffusion Tensor Imaging Early and Long-Term Results
    Anik, Ihsan
    Anik, Yonca
    Cabuk, Burak
    Caklili, Melih
    Pirhan, Dilara
    Ozturk, Onural
    Cirak, Musa
    Ceylan, Savas
    WORLD NEUROSURGERY, 2018, 112 : E691 - E701
  • [4] The HACKD Score-Predicting Extent of Resection of Pituitary Macroadenomas Through an Endoscopic Endonasal Transsphenoidal Approach
    Castle-Kirszbaum, Mendel
    Wang, Yi Yuen
    King, James
    Kam, Jeremy
    Goldschlager, Tony
    OPERATIVE NEUROSURGERY, 2023, 24 (02) : 154 - 161
  • [5] Endoscopic Endonasal Pituitary Surgery For Nonfunctioning Pituitary Adenomas: Long-Term Outcomes and Management of Recurrent Tumors
    Bernat, Anne-Laure
    Troude, Penelope
    Priola, Stefano Maria
    Elsawy, Ahmad
    Farrash, Faisal
    Mete, Ozgur
    Ezzat, Shereen
    Asa, Sylvia L.
    De Almeida, John
    Vescan, Allan
    Monteiro, Eric
    Almeida, Joao Paulo
    Zadeh, Gelareh Mohammed
    Gentili, Fred
    WORLD NEUROSURGERY, 2021, 146 : E341 - E350
  • [6] Primary versus revision transsphenoidal resection for nonfunctioning pituitary macroadenomas: matched cohort study
    Przybylowski, Colin J.
    Dallapiazza, Robert F.
    Williams, Brian J.
    Pomeraniec, I. Jonathan
    Xu, Zhiyuan
    Payne, Spencer C.
    Laws, Edward R.
    Jane, John A., Jr.
    JOURNAL OF NEUROSURGERY, 2017, 126 (03) : 889 - 896
  • [7] Endoscopic endonasal resection of nonfunctioning pituitary adenoma with radiological calcification
    Xie, Zhengxing
    Wang, Qing
    Lu, Xiaojie
    PITUITARY, 2019, 22 (04) : 381 - 386
  • [8] Long-term olfactory function outcomes after pituitary surgery by endoscopic endonasal transsphenoidal approach
    Kuwata, Fumihiko
    Kikuchi, Masahiro
    Ishikawa, Masaaki
    Tanji, Masahiro
    Sakamoto, Tatsunori
    Yamashita, Masaru
    Matsunaga, Mami
    Omori, Koichi
    Nakagawa, Takayuki
    AURIS NASUS LARYNX, 2020, 47 (02) : 227 - 232
  • [9] Results of Endoscopic Endonasal Transsphenoidal Surgery for Pituitary Adenomas
    Tataranu, L.
    Ciubotaru, V
    Dediu, A.
    PAPERS PRESENTED AT THE EANS ANNUAL MEETING, 2012, : 61 - 64
  • [10] Surgical complications of the transsphenoidal endonasal endoscopic approach to pituitary macroadenomas: single center study
    Almendarez-Sanchez, Cesar A.
    Garcia-Velasco, Hugo
    Ramirez-Sosa, Miguel A.
    Tevera-Ovando, Carlos A.
    Lopez-Zapata, Javier
    Ruiz-Flores, Milton
    Huato-Reyes, Raul
    CIRUGIA Y CIRUJANOS, 2021, 89 (04): : 484 - 489